Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral insulin for primary prevention of type 1 diabetes (Pre-POINT-Early)
NCT02547519Phase 2Completed
- Sponsor
- Technical University of Munich
- Start
- Aug 2015
- Primary completion
- Dec 2017
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 1 diabetes mellitus (T1D) comparing Oral Insulin with Placebo (2 arms). Primary endpoints: Activation of a CD4+ T cell immune response against insulin at 12 months and Activation of an antibody response against insulin at 12 months. Started Aug 2015; status: completed.
02
Drugs
human insulin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02547519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02547519.